Results of a phase II study investigating venetoclax in patients with relapsed/refractory Waldenstrom Macroglobulinemia.
Home / Resource Library / Multicenter Prospective Phase II Study of Venetoclax in Patients with Previously Treated Waldenstrom Macroglobulinemia